MBNL1 and myotonic dystrophy type 1: Further experiments showed that these (CAG)2 MPγPNAs conjugated to aromatic moieties specifically discriminate CUG-expanded mRNAs from normal length transcripts and prevent their interaction with MBNL1, making it an interesting candidate for treating DM1.